GKB Ophthalmics Ltd (GKB) is currently trading at 64.36 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

GKB Ophthalmics specializes in manufacturing and exporting unfinished ophthalmic lenses from Goa, India. The company has robust production capabilities with an installed capacity of 3 million lenses per annum. A strategic move was establishing a subsidiary in Germany, aiding market expansion into Europe. GKB started producing CR 39 lenses in 2007, indicating product line diversification. Recent ventures into producing Hi-Index lenses faced financial challenges, prompting reconsideration of expansion strategies.

Over the past 52 weeks, GKB Ophthalmics Ltd has traded between a low of ₹45.25 and a high of ₹76.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

GKB Ophthalmics Ltd has a market capitalization of approximately 32.44. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

GKB Ophthalmics Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 6.47 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 32.44 Cr, GKB Ophthalmics Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

GKB Ophthalmics Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of GKB Ophthalmics Ltd is 6.47. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Consolidated net sales were reported at Rs 29.79 crore for the quarter ended March 2026, down 3.97% from Rs 31.02 crore in the March 2025 quarter.